KPV is a short tripeptide studied in vitro in inflammation research, where its interaction with inflammatory-signaling pathways is measured in cell models. This profile describes the compound and how it is studied.
What is KPV?
KPV is a synthetic tripeptide (three amino acids) used as a reference compound. It is described here only by structure and molecular target, as a laboratory material.
What it is studied for
In inflammation research, KPV is studied for its interaction with signaling pathways that regulate inflammatory responses in cultured cells. The focus is on mechanism in a controlled system.
How it is studied in vitro
Researchers use cell-based assays that read out inflammatory markers, such as cytokine levels or activation of a signaling pathway, comparing conditions against controls.
Why a short peptide is useful
A small, well-defined peptide is a convenient tool for probing a specific pathway, because its chemistry is simple to characterize and reproduce.
KPV is also the fourth component of the KLOW peptide blend, where it is co-formulated with BPC-157, TB-500 and GHK-Cu; what it adds to that composition is set out in GLOW vs KLOW.
Related research guides
- Immune & anti-inflammatory (overview)
- Thymosin alpha-1 (immune signaling)
- Cytokine signaling & NF-kB
- KLOW peptide blend: components and in-vitro research profile
- What is KLOW peptide? Component-by-component breakdown
Research-use note
KPV is supplied as a research material for in vitro research use only. It is not for human or animal use.
Related research: KPV.








